{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:50:40Z","timestamp":1740124240059,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20212BAB216020"],"award-info":[{"award-number":["20212BAB216020"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project of Administration of Traditional Chinese Medicine of Jiangxi Province of China","award":["2020Z020"],"award-info":[{"award-number":["2020Z020"]}]},{"name":"the Science and Technology Program of Jiangxi Health Commission","award":["20195075"],"award-info":[{"award-number":["20195075"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-023-03514-3","type":"journal-article","created":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T02:14:41Z","timestamp":1676772881000},"page":"2015-2023","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low-density lipoprotein cholesterol to apolipoprotein B ratio predicts mortality and cardiovascular events in peritoneal dialysis patients"],"prefix":"10.1007","volume":"55","author":[{"given":"Chuanfei","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linghai","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2371-1350","authenticated-orcid":false,"given":"Xiaojiang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,18]]},"reference":[{"issue":"3","key":"3514_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/j.ajkd.2020.05.032","volume":"77","author":"Y Cho","year":"2021","unstructured":"Cho Y, Bello A, Levin A, Lunney M, Osman M, Ye F et al (2021) Peritoneal dialysis use and practice patterns: an international survey study. Am J Kidney Dis 77(3):315\u2013325. https:\/\/doi.org\/10.1053\/j.ajkd.2020.05.032","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"3514_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41581-020-0315-4","volume":"16","author":"J Himmelfarb","year":"2020","unstructured":"Himmelfarb J, Vanholder R, Mehrotra R, Tonelli M (2020) The current and future landscape of dialysis. Nat Rev Nephrol 16(10):573\u2013585. https:\/\/doi.org\/10.1038\/s41581-020-0315-4","journal-title":"Nat Rev Nephrol"},{"key":"3514_CR3","volume-title":"2020 USRDS annual data report: epidemiology of kidney disease in the United States","author":"USRD System","year":"2020","unstructured":"System USRD (2020) 2020 USRDS annual data report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD"},{"issue":"1","key":"3514_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12882-016-0394-4","volume":"17","author":"K Cai","year":"2016","unstructured":"Cai K, Luo Q, Zhu B, Han L, Wu D, Dai Z et al (2016) Neutrophil-lymphocyte ratio is associated with arterial stiffness in patients with peritoneal dialysis. BMC Nephrol 17(1):191. https:\/\/doi.org\/10.1186\/s12882-016-0394-4","journal-title":"BMC Nephrol"},{"issue":"9438","key":"3514_CR5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/s0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, \u00d4unpuu S, Dans T, Avezum A, Lanas F et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937\u2013952. https:\/\/doi.org\/10.1016\/s0140-6736(04)17018-9","journal-title":"Lancet"},{"issue":"4","key":"3514_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/HCO.0000000000000740","volume":"35","author":"A Wolska","year":"2020","unstructured":"Wolska A, Remaley AT (2020) Measuring LDL-cholesterol: what is the best way to do it? Curr Opin Cardiol 35(4):405\u2013411. https:\/\/doi.org\/10.1097\/HCO.0000000000000740","journal-title":"Curr Opin Cardiol"},{"issue":"24","key":"3514_CR7","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Boren","year":"2020","unstructured":"Boren J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ et al (2020) Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European atherosclerosis society consensus panel. Eur Heart J 41(24):2313\u20132330. https:\/\/doi.org\/10.1093\/eurheartj\/ehz962","journal-title":"Eur Heart J"},{"key":"3514_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ijcard.2017.06.105","volume":"248","author":"W Zhao","year":"2017","unstructured":"Zhao W, Zheng XL, Jiang ZN, Liao XB, Zhao SP (2017) Risk factors associated with atherogenic dyslipidemia in the presence of optimal statin therapy. Int J Cardiol 248:355\u2013360. https:\/\/doi.org\/10.1016\/j.ijcard.2017.06.105","journal-title":"Int J Cardiol"},{"issue":"2","key":"3514_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5551\/jat.12.67","volume":"12","author":"T Hirano","year":"2005","unstructured":"Hirano T, Ito Y, Yoshino G (2005) Measurement of small dense low-density lipoprotein particles. J Atheroscler Thromb 12(2):67\u201372. https:\/\/doi.org\/10.5551\/jat.12.67","journal-title":"J Atheroscler Thromb"},{"issue":"15","key":"3514_CR10","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1001\/jama.2018.2525","volume":"319","author":"EP Navarese","year":"2018","unstructured":"Navarese EP, Robinson JG, Kowalewski M, Kolodziejczak M, Andreotti F, Bliden K et al (2018) Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis. JAMA 319(15):1566\u20131579. https:\/\/doi.org\/10.1001\/jama.2018.2525","journal-title":"JAMA"},{"issue":"1","key":"3514_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cjca.2019.08.028","volume":"36","author":"H Ye","year":"2020","unstructured":"Ye H, Wu H, Peng Y, Zhou Q, Cao P, Guo Q et al (2020) Peritonitis affects the relationship between low-density lipoprotein cholesterol and cardiovascular events in peritoneal dialysis patients. Can J Cardiol 36(1):92\u201399. https:\/\/doi.org\/10.1016\/j.cjca.2019.08.028","journal-title":"Can J Cardiol"},{"issue":"9 Suppl 4","key":"3514_CR12","doi-asserted-by":"publisher","first-page":"S315","DOI":"10.1097\/01.asn.0000081698.10331.83","volume":"14","author":"SS Prichard","year":"2003","unstructured":"Prichard SS (2003) Impact of dyslipidemia in end-stage renal disease. J Am Soc Nephrol 14(9 Suppl 4):S315\u2013S320. https:\/\/doi.org\/10.1097\/01.asn.0000081698.10331.83","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3514_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/089686080202200209","volume":"22","author":"J Moberly","year":"2002","unstructured":"Moberly J, Attman P, Samuelsson O, Johansson A, Knight-Gibson C, Alaupovic P (2002) Alterations in lipoprotein composition in peritoneal dialysis patients. Perit Dial Int 22(2):220\u2013228","journal-title":"Perit Dial Int"},{"issue":"6","key":"3514_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1536\/ihj.52.343","volume":"52","author":"S Tani","year":"2011","unstructured":"Tani S, Saito Y, Anazawa T, Kawamata H, Furuya S, Takahashi H et al (2011) Low-density lipoprotein cholesterol\/apolipoprotein B ratio may be a useful index that differs in statin-treated patients with and without coronary artery disease: a case control study. Int Heart J 52(6):343\u2013347. https:\/\/doi.org\/10.1536\/ihj.52.343","journal-title":"Int Heart J"},{"key":"3514_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2021.05.010","volume":"329","author":"H Drexel","year":"2021","unstructured":"Drexel H, Larcher B, Mader A, Vonbank A, Heinzle C, Moser B et al (2021) The LDL-C\/ApoB ratio predicts major cardiovascular events in patients with established atherosclerotic cardiovascular disease. Atherosclerosis 329:44\u201349. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.05.010","journal-title":"Atherosclerosis"},{"key":"3514_CR16","doi-asserted-by":"publisher","DOI":"10.5551\/jat.60954","author":"N Akutsu","year":"2021","unstructured":"Akutsu N, Hori K, Mizobuchi S, Ogaku A, Koyama Y, Fujito H et al (2021) Clinical importance of the LDL-C\/apolipoprotein B ratio for neointimal formation after everolimus-eluting stent implantations. J Atheroscler Thromb. https:\/\/doi.org\/10.5551\/jat.60954","journal-title":"J Atheroscler Thromb"},{"issue":"5","key":"3514_CR17","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.numecd.2021.01.013","volume":"31","author":"S Rabizadeh","year":"2021","unstructured":"Rabizadeh S, Rajab A, Mechanick JI, Moosaie F, Rahimi Y, Nakhjavani M et al (2021) LDL\/apo B ratio predict coronary heart disease in Type 2 diabetes independent of ASCVD risk score: a case-cohort study. Nutr Metab Cardiovasc Dis 31(5):1477\u20131485. https:\/\/doi.org\/10.1016\/j.numecd.2021.01.013","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"21","key":"3514_CR18","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.Ccr-04-0713","volume":"10","author":"R Camp","year":"2004","unstructured":"Camp R, Dolled-Filhart M, Rimm D (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252\u20137259. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-04-0713","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3514_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-018-0771-z","volume":"17","author":"X Zhan","year":"2018","unstructured":"Zhan X, Chen Y, Yan C, Liu S, Deng L, Yang Y et al (2018) Apolipoprotein B\/apolipoprotein A1 ratio and mortality among incident peritoneal dialysis patients. Lipids Health Dis 17(1):117. https:\/\/doi.org\/10.1186\/s12944-018-0771-z","journal-title":"Lipids Health Dis"},{"issue":"6","key":"3514_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001363","volume":"3","author":"DC Wheeler","year":"2014","unstructured":"Wheeler DC, London GM, Parfrey PS, Block GA, Correa-Rotter R, Dehmel B et al (2014) Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the evaluation Of Cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial. J Am Heart Assoc 3(6):e001363. https:\/\/doi.org\/10.1161\/JAHA.114.001363","journal-title":"J Am Heart Assoc"},{"issue":"9784","key":"3514_CR21","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/s0140-6736(11)60739-3","volume":"377","author":"C Baigent","year":"2011","unstructured":"Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C et al (2011) The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial. Lancet 377(9784):2181\u20132192. https:\/\/doi.org\/10.1016\/s0140-6736(11)60739-3","journal-title":"Lancet"},{"issue":"9753","key":"3514_CR22","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/s0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Baigent C, Blackwell L, Emberson J, Holland L, Reith C, Bhala N et al (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376(9753):1670\u20131681. https:\/\/doi.org\/10.1016\/s0140-6736(10)61350-5","journal-title":"Lancet"},{"issue":"11","key":"3514_CR23","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.ekir.2019.07.014","volume":"4","author":"ZA Massy","year":"2019","unstructured":"Massy ZA, Ferrieres J, Bruckert E, Lange C, Liabeuf S, Velkovski-Rouyer M et al (2019) Achievement of low-density lipoprotein cholesterol targets in CKD. Kidney Int Rep 4(11):1546\u20131554. https:\/\/doi.org\/10.1016\/j.ekir.2019.07.014","journal-title":"Kidney Int Rep"},{"issue":"6","key":"3514_CR24","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1053\/j.ajkd.2018.11.010","volume":"73","author":"A Bajaj","year":"2019","unstructured":"Bajaj A, Xie D, Cedillo-Couvert E, Charleston J, Chen J, Deo R et al (2019) Lipids, apolipoproteins, and risk of atherosclerotic cardiovascular disease in persons with CKD. Am J Kidney Dis 73(6):827\u2013836. https:\/\/doi.org\/10.1053\/j.ajkd.2018.11.010","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"3514_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12882-021-02375-1","volume":"22","author":"B Wang","year":"2021","unstructured":"Wang B, Chen S, Liu J, Liang Y, Meng L, Yan X et al (2021) Association between baseline LDL-C and prognosis among patients with coronary artery disease and advanced kidney disease. BMC Nephrol 22(1):168. https:\/\/doi.org\/10.1186\/s12882-021-02375-1","journal-title":"BMC Nephrol"},{"issue":"1","key":"3514_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11154-016-9402-z","volume":"18","author":"MR Hager","year":"2017","unstructured":"Hager MR, Narla AD, Tannock LR (2017) Dyslipidemia in patients with chronic kidney disease. Rev Endocr Metab Disord 18(1):29\u201340. https:\/\/doi.org\/10.1007\/s11154-016-9402-z","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"3514_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","volume":"27","author":"J Boren","year":"2016","unstructured":"Boren J, Williams KJ (2016) The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr Opin Lipidol 27(5):473\u2013483. https:\/\/doi.org\/10.1097\/MOL.0000000000000330","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"3514_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11255-017-1737-1","volume":"50","author":"M Ye","year":"2018","unstructured":"Ye M, Liu Y, Wang H, Tian N, Li W, He W et al (2018) Serum apolipoprotein B is inversely associated with eccentric left ventricular hypertrophy in peritoneal dialysis patients. Int Urol Nephrol 50(1):155\u2013165. https:\/\/doi.org\/10.1007\/s11255-017-1737-1","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"3514_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0021-9150(89)90032-4","volume":"79","author":"J Steele","year":"1989","unstructured":"Steele J, Billington T, Janus E, Moran J (1989) Lipids, lipoproteins and apolipoproteins A-I and B and apolipoprotein losses in continuous ambulatory peritoneal dialysis. Atherosclerosis 79(1):47\u201350. https:\/\/doi.org\/10.1016\/0021-9150(89)90032-4","journal-title":"Atherosclerosis"},{"issue":"5","key":"3514_CR30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.2215\/CJN.09830915","volume":"11","author":"Y Sato","year":"2016","unstructured":"Sato Y, Fujimoto S, Toida T, Nakagawa H, Yamashita Y, Iwakiri T et al (2016) Apoprotein B\/apoprotein A-1 ratio and mortality among prevalent dialysis patients. Clin J Am Soc Nephrol 11(5):840\u2013846. https:\/\/doi.org\/10.2215\/CJN.09830915","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"3514_CR31","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s11745-010-3408-1","volume":"45","author":"K Musunuru","year":"2010","unstructured":"Musunuru K (2010) Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. Lipids 45(10):907\u2013914. https:\/\/doi.org\/10.1007\/s11745-010-3408-1","journal-title":"Lipids"},{"issue":"3","key":"3514_CR32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/01.ATV.0000154144.73236.f4","volume":"25","author":"AC St-Pierre","year":"2005","unstructured":"St-Pierre AC, Cantin B, Dagenais GR, Mauriege P, Bernard PM, Despres JP et al (2005) Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec cardiovascular study. Arterioscler Thromb Vasc Biol 25(3):553\u2013559. https:\/\/doi.org\/10.1161\/01.ATV.0000154144.73236.f4","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"3514_CR33","doi-asserted-by":"publisher","first-page":"771","DOI":"10.5301\/JN.2011.6376","volume":"24","author":"RG Bowden","year":"2011","unstructured":"Bowden RG, Wilson RL, Beaujean AA (2011) LDL particle size and number compared with LDL cholesterol and risk categorization in end-stage renal disease patients. J Nephrol 24(6):771\u2013777. https:\/\/doi.org\/10.5301\/JN.2011.6376","journal-title":"J Nephrol"},{"issue":"4","key":"3514_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s005920200037","volume":"39","author":"A W\u00e4gner","year":"2002","unstructured":"W\u00e4gner A, Jorba O, Rigla M, Alonso E, Ord\u00f3\u00f1ez-Llanos J, P\u00e9rez A (2002) LDL-cholesterol\/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes. Acta Diabetol 39(4):215\u2013220. https:\/\/doi.org\/10.1007\/s005920200037","journal-title":"Acta Diabetol"},{"issue":"10","key":"3514_CR35","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/s0002-9149(03)00262-5","volume":"91","author":"A Sniderman","year":"2003","unstructured":"Sniderman A, St-Pierre A, Cantin B, Dagenais G, Despr\u00e9s J, Lamarche B (2003) Concordance\/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk. Am J Cardiol 91(10):1173\u20131177. https:\/\/doi.org\/10.1016\/s0002-9149(03)00262-5","journal-title":"Am J Cardiol"},{"issue":"7","key":"3514_CR36","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.amjcard.2005.10.062","volume":"97","author":"I Jungner","year":"2006","unstructured":"Jungner I, Sniderman A, Furberg C, Aastveit A, Holme I, Walldius G (2006) Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction? Am J Cardiol 97(7):943\u2013946. https:\/\/doi.org\/10.1016\/j.amjcard.2005.10.062","journal-title":"Am J Cardiol"},{"key":"3514_CR37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.atherosclerosis.2016.06.029","volume":"251","author":"JC Bae","year":"2016","unstructured":"Bae JC, Han JM, Kwon S, Jee JH, Yu TY, Lee MK et al (2016) LDL-C\/apoB and HDL-C\/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort. Atherosclerosis 251:170\u2013176. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.06.029","journal-title":"Atherosclerosis"},{"issue":"3","key":"3514_CR38","first-page":"199","volume":"25","author":"B Lamarche","year":"1999","unstructured":"Lamarche B, Lemieux I, Despr\u00e9s JP (1999) The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab 25(3):199\u2013211","journal-title":"Diabetes Metab"},{"issue":"1","key":"3514_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0026-0495(00)90688-7","volume":"49","author":"G Leroux","year":"2000","unstructured":"Leroux G, Lemieux I, Lamarche B, Cantin B, Dagenais G, Lupien P et al (2000) Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels. Metabolism 49(1):53\u201361. https:\/\/doi.org\/10.1016\/s0026-0495(00)90688-7","journal-title":"Metabolism"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03514-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03514-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03514-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T16:05:38Z","timestamp":1688832338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03514-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,18]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["3514"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03514-3","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2023,2,18]]},"assertion":[{"value":"12 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have declared no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (IRB approval number: [2021] 9\u2013028) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}]}}